Global Diabetes Devices Market Size, Share & Trends Analysis Report, By Device Type, By Distribution Channel, By Technology, By Region, And Segment Forecasts, 2024 - 2031
- Published Date : 2024-10-01
- Pages : 100
- Report Id : 40486
- Categories : Healthcare
This report describes the global market size of the Diabetes Devices Market from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and is expected to grow with a CAGR of 7.45 % from 2024 to 2031.
Due to the COVID-19 pandemic and the Russia-Ukraine War Influence, the global market for Diabetes Devices Market estimated at US $15.25 Billion in the year 2022, is projected to reach a revised size of US $ 29.41 Billion by 2031, growing at a CAGR of 7.45 % during the forecast period 2024-2031.
Diabetic devices refer to a range of medical instruments and technologies designed to help individuals with diabetes manage their blood glucose levels effectively. These devices include glucometers, which are used to monitor blood sugar levels by testing a small drop of blood, and continuous glucose monitors (CGMs), which provide real-time glucose readings throughout the day via sensors placed under the skin. Insulin pumps deliver insulin continuously and can be programmed to adjust dosages based on glucose readings. Other devices include insulin pens and syringes, used for administering insulin manually. Advanced systems, such as closed-loop systems or artificial pancreas devices, combine CGMs and insulin pumps to automatically regulate insulin delivery. These technologies play a crucial role in preventing complications associated with diabetes by enabling precise, consistent monitoring and management of blood sugar levels. With innovations like smartphone-connected devices and data-sharing capabilities, diabetic devices are becoming more user-friendly and integrated into daily life, improving outcomes for those managing the disease.
For the geography segment, regional supply, demand, major players, and price is presented from 2019 to 2031. This report covers the following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report include global key players of Diabetes Devices Market as well as some small players. The information for each competitor includes:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Device Type
Blood Glucose Monitoring Devices:
Self-monitoring Blood Glucose (SMBG) Devices:
Continuous Glucose Monitoring (CGM) Systems:
Sensors
Transmitters and receivers
HbA1c Testing Kits:
Point-of-care HbA1c devices
Laboratory HbA1c testing devices
Insulin Delivery Devices:
Insulin Pens
Insulin Pumps
Insulin Syringes
Insulin Jet Injectors
Diabetes Management Software
Artificial Pancreas Systems
The diabetic devices market can be segmented by device type, including blood glucose monitoring devices and insulin delivery devices, among others. Blood glucose monitoring devices encompass Self-Monitoring Blood Glucose (SMBG) devices, which allow patients to manually check their blood glucose levels, and Continuous Glucose Monitoring (CGM) systems, which include components such as sensors, transmitters, and receivers to track glucose levels in real-time. CGMs provide continuous data, improving glucose management over SMBG alone. HbA1c testing kits measure long-term blood sugar control, with options like point-of-care devices for instant results and laboratory HbA1c testing devices for detailed analysis. Insulin delivery devices consist of insulin pens, insulin pumps, insulin syringes, and more advanced options like insulin jet injectors that deliver insulin without needles. Diabetes management software helps patients track data from these devices, providing insights to optimize treatment. Artificial pancreas systems integrate CGMs with insulin pumps, automatically adjusting insulin levels based on real-time glucose readings, offering a more automated and efficient way to manage diabetes. These advanced tools are revolutionizing diabetic care by enabling better glucose control and improving patient outcomes.
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Diabetes Clinics
Home Care Settings
Diabetic devices are distributed through a variety of channels, each catering to different patient needs and preferences. Hospital pharmacies play a crucial role in supplying diabetic devices, especially to inpatients or those receiving treatment in a clinical setting. They offer products like blood glucose monitors, insulin pumps, and testing kits as part of hospital care plans. Retail pharmacies are a more accessible option for patients to purchase diabetic devices, such as insulin pens and glucometers, on an outpatient basis. These pharmacies provide personal interaction and guidance from pharmacists. Online pharmacies have gained popularity for their convenience, allowing patients to order diabetic devices from home with quick delivery, often offering a wider selection and competitive pricing. Diabetes clinics specialize in comprehensive care for diabetes patients, offering specialized devices, continuous glucose monitoring systems, and insulin delivery devices tailored to individual care plans. Finally, home care settings are increasingly important for long-term diabetes management, as patients manage their condition independently. In-home use of devices like CGMs, insulin pumps, and diabetes management software allows for ongoing monitoring and treatment without the need for frequent clinic visits, empowering patients to manage their condition effectively.
By Technology (for CGM and Insulin Delivery Devices)
Wearable Devices
Non-invasive Devices
Implantable Devices
In the diabetic devices market, advancements in technology have transformed Continuous Glucose Monitoring (CGM) and insulin delivery devices into more effective and user-friendly solutions. Wearable devices have become increasingly popular, allowing patients to continuously monitor their glucose levels or receive insulin via compact devices worn on the body. CGMs with wearable sensors provide real-time glucose readings, while insulin pumps are also worn discreetly, delivering insulin throughout the day. Non-invasive devices represent a breakthrough in diabetic care, eliminating the need for traditional finger-pricking or injections. These devices measure glucose levels through alternative methods like interstitial fluid or even sweat, providing a painless solution for glucose monitoring. Similarly, non-invasive insulin delivery methods, like insulin jet injectors, bypass the need for needles. Implantable devices offer even greater convenience and long-term solutions. Some CGM systems now come with implantable sensors that can remain under the skin for extended periods, reducing the need for frequent sensor replacement. Implantable insulin pumps, though less common, provide automated insulin delivery without the need for external devices, giving patients a seamless experience. These technological advancements aim to improve diabetes management, enhancing comfort, accuracy, and lifestyle flexibility for patients.
Key Players
Medtronic plc
Abbott Laboratories
F.Hoffmann-La-Ltd.
Bayer AG; Lifescan, Inc.
B Braun Melsungen AG
Lifescan, Inc.
Dexcom Inc.
Insulet Corporation
Ypsomed Holdings
Companion Medical
Sanofi
Valeritas Holding Inc.
Novo Nordisk A/S
Arkray, Inc.
Please ask for sample pages for the full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
TABLE OF CONTENTS
Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.Diabetes Devices Market Outlook
3.1.2.Diabetes Devices Market Overview
3.2. Effect of Covid-19 Impact
3.3. Macro-Economic Overview
3.3.1. GDP Growth
3.3.2. Retail Industry Growth
3.4. Pricing Analysis
3.5. Challenges related to adoption of Diabetes Devices Market
3.6. Regulations of Diabetes Devices Market
3.7. Forecast Factors: Relevance and Impact
3.8. Market Dynamics
3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunity
3.8.4. Trends
3.8.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global Diabetes Devices Market Value Chain Analysis
5.1.Diabetes Devices Market Value Chain
5.1.1. List of Raw Distribution Channel Suppliers
5.1.2. List of Diabetes Devices Market Manufacturer
5.1.3. List of Segment
6. Global Diabetes Devices Market Analysis by Device Type
6.1. Introduction
6.1.1. Market Value Share Analysis By Device Type
6.1.2. Y-o-Y Growth Analysis By Device Type
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Device Type
6.3. Market Attractiveness Analysis by Device Type
7. GlobalDiabetes Devices Market Analysis By Distribution Channel
7.1. Introduction
7.1.1. Market Value Share Analysis By Distribution Channel
7.1.2. Y-o-Y Growth Analysis By Distribution Channel
7.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Distribution Channel
7.3. Market Attractiveness Analysis By Distribution Channel
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Device Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Device Type Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1.Medtronic plc
9.2.1.1. Overview
9.2.1.2. Device Type Portfolio
9.2.1.3. Financial Overview
9.2.2.Abbott Laboratories
9.2.2.1. Overview
9.2.2.2. Device Type Portfolio
9.2.2.3. Financial Overview
9.2.3.F.Hoffmann-La-Ltd.
9.2.3.1. Overview
9.2.3.2. Device Type Portfolio
9.2.3.3. Financial Overview
9.2.4. Bayer AG; Lifescan, Inc.
9.2.4.1. Overview
9.2.4.2. Device Type Portfolio
9.2.4.3. Financial Overview
9.2.5. B Braun Melsungen AG
9.2.5.1. Overview
9.2.5.2. Device Type Portfolio
9.2.5.3. Financial Overview
9.2.6.E.I. Lifescan, Inc.
9.2.6.1. Overview
9.2.6.2. Device Type Portfolio
9.2.6.3. Financial Overview
9.2.7.Dexcom Inc.
9.2.7.1. Overview
9.2.7.2. Device Type Portfolio
9.2.7.3. Financial Overview
9.2.8.Insulet Corporation
9.2.8.1. Overview
9.2.8.2. Device Type Portfolio
9.2.8.3. Financial Overview
9.2.9. Ypsomed Holdings
9.2.9.1. Overview
9.2.9.2. Device Type Portfolio
9.2.9.3. Financial Overview
9.2.10.Companion Medical
9.2.10.1. Overview
9.2.10.2. Device Type Portfolio
9.2.10.3. Financial Overview
9.2.11.Sanofi
9.2.11.1. Overview
9.2.11.2. Device Type Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY 12
9.2.12.1. Overview
9.2.12.2. Device Type Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY 13
9.2.13.1. Overview
9.2.13.2. Device Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY 14
9.2.14.1. Overview
9.2.14.2. Device Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY 15
9.2.15.1. Overview
9.2.15.2. Device Type Portfolio
9.2.15.3. Financial Overview
10. Global Diabetes Devices Market Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y-o-Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia-Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia-Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America Diabetes Devices Market Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Device Type
11.5. Current Market Size (USD Mn) Forecast 2023-2030 By Device Type
11.6. Historical Market Size (USD Mn) Analysis 2018-2022 By Distribution Channel
11.7. Current Market Size (USD Mn) Forecast 2023-2030 By Distribution Channel
12. South America Diabetes Devices Market Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Device Type
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Device Type
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Distribution Channel
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By Distribution Channel
13. Europe Diabetes Devices Market Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Device Type
13.6. Current Market Size (USD Mn) Forecast 2023-2030 By Device Type
13.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Distribution Channel
13.8. Current Market Size (USD Mn) Forecast 2023-2030 By Distribution Channel
14. Middle East and Africa Diabetes Devices Market Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia-Pacific Diabetes Devices Market Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia-Pacific
15.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms
LIST OF FIGURES
Figure 01: Global Diabetes Devices Market, BPS Analysis,By Device Type, 2018(H), 2023(E) & 2030(F)
Figure 02: Global Diabetes Devices Market, Y-O-Y Growth,By Device Type, 2020(A) - 2030(F)
Figure 03: Global Diabetes Devices Market Attractiveness Analysis,By Device Type (2020)
Figure 04: Global Diabetes Devices Market, BPS Analysis, By Distribution Channel, 2018(H), 2023(E) & 2030(F)
Figure 05: Global Diabetes Devices Market, Y-O-Y Growth, By Distribution Channel, 2018(H) - 2030(F)
Figure 06: Global Diabetes Devices Market Attractiveness Analysis, By Distribution Channel
Figure 07: Global Diabetes Devices Market, Value Analysis,By Device Type, 2018(H)-2030(F)
Figure 08: Global Diabetes Devices Market, Value Analysis, by Distribution Channel , 2018(H)-2030(F)
Figure 09: Global Diabetes Devices Market, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Diabetes Devices Market, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global Diabetes Devices Market Attractiveness Analysis, by Region
Figure 12: North America Diabetes Devices Market Value (USD Mn Forecast, 2018 – 2022
Figure 13: North America Diabetes Devices Market Value (USD Mn Forecast, 2023 – 2030
Figure 14: South America Diabetes Devices Market Value (USD Mn) Forecast, 2018 – 2022
Figure 15: South America Diabetes Devices Market Value (USD Mn) Forecast, 2023 – 2030
Figure 16: Europe Diabetes Devices Market Value (USD Mn) Forecast, 2018 – 2022
Figure 17: Europe Diabetes Devices Market Value (USD Mn) Forecast, 2023 – 2030
Figure 18: Middle East and Africa Diabetes Devices Market Value (USD Mn) Forecast, 2018 – 2022
LIST OF TABLES
Table 01: Global Diabetes Devices Market Value (USD Mn) Forecast, By Device Type, 2018(H) – 2030(F)
Table 02: Global Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel, 2018(H) – 2030(F)
Table 03: Global Diabetes Devices Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 04: North America Diabetes Devices Market Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 05: North America Diabetes Devices Market Value (USD Mn) Forecast,By Device Type, 2018(H) – 2030(F)
Table 06: North America Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel, 2018(H) – 2030(F)
Table 07: South America Diabetes Devices Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 08: South America Diabetes Devices Market Value (USD Mn) Forecast,By Device Type, 2018(H) – 2030(F)
Table 09: South America Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel, 2018(H) – 2030(F)
Table 10: Europe Diabetes Devices Market Value (USD Mn) and Forecast, by Country, 2018(H) – 2030(F)
Table 11: Europe Diabetes Devices Market Value (USD Mn) Forecast, By Device Type, 2018(H) – 2030(F)
Table 12: Europe Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel EndUser, 2018(H) – 2030(F)
Table 13: Middle East and Africa Diabetes Devices Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 14: Middle East and Africa Diabetes Devices Market Value (USD Mn) Forecast, By Device Type, 2018(H) – 2030(F)
Table 15: Middle East and Africa Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel, 2018(H) – 2030(F)
Table 16: Asia-Pacific Diabetes Devices Market Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 17: Asia-Pacific Diabetes Devices Market Value (USD Mn) Forecast, By Device Type, 2018(H) – 2030(F)
Table 18: Asia-Pacific Diabetes Devices Market Value (USD Mn) Forecast, By Distribution Channel, 2018(H) – 2030(F)
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research ™ Copyright © 2024 .